Account
Cart

No products in the cart.

CATEGORIES

Marathon Money Exclusive: OS Therapies (NYSE: OSTX) CBO Interview Reveals FDA Meeting In Q2 2025 Milestones, $150M Revenue Boost, and $500M Market Opportunity

Global Innovators Series Marathon Money Podcast

In this in-depth conversation, we dive straight into the company’s bold plans for the next 12 to 18 months:

Spoiler Alert: Minute 29 is a must-watch. This is where we dig into the specifics of FDA pathways, commercialization timelines, and why OS Therapies believes it can be a transformational player in biotech.

While the video of our exclusive interview with OS Therapies’ Chief Business Officer, Gerald Commissiong, is completely free, you’ll need to sign up for our Future 1%er membership to access it. The Future 1%er membership is entirely free, making this the easiest step toward gaining actionable insights on OSTX and beyond.

This content is for Pro Membership, Elite Membership 2 Free Months , Standard Membership, Future 1% Membership, and CEO Interview Access one-time fee members only.
Join Now

Listen to the Free Version of Marathon Money
Listen on Apple Podcasts

These are publicly available episodes that anyone can access on Spotify or Apple Podcasts.
Exclusive Content : Premium content only available to members who join. It offers additional insights, interviews, or behind-the-scenes information not found in the free versions.
Already a member? Log in here

Marathon Money: Unlock My OSTX Trading Strategy

OS Therapies Inc. (NYSE: OSTX) We’ve created two powerful trading strategies—a buying strategy and a shorting strategy—tailored to maximize your potential returns based on key milestones like FDA approval, commercialization, and market expansion.

But here’s the deal: these strategies are NOT free.

To access them, you’ll need to sign up for the one-time free CEO interview membership on Marathon Money. This membership gives you exclusive access to my insights, strategies, and the tools I’ll personally use to trade OSTX.

If you are already monthly Member Just Log in

Below are two detailed trading strategies for OS Therapies (NYSE: OSTX)—one for buying and one for shorting. These strategies take into account typical biotech trading patterns, catalysts like FDA milestones, and the inherent risks and volatility of small-cap stocks.

This content is for CEO Interview Access one-time fee, Pro Membership, Elite Membership 2 Free Months , and Standard Membership members only.
Join Now

Listen to the Free Version of Marathon Money
Listen on Apple Podcasts

These are publicly available episodes that anyone can access on Spotify or Apple Podcasts.
Exclusive Content : Premium content only available to members who join. It offers additional insights, interviews, or behind-the-scenes information not found in the free versions.
Already a member? Log in here


Discover more from Marathon Money +

Subscribe to get the latest posts sent to your email.

To top

Discover more from Marathon Money +

Subscribe now to keep reading and get access to the full archive.

Continue reading